AI-driven adverse events monitoring

    Leverage process excellence for data capture and transmission, expertise in signal detection with advanced analytics, and data harmonization using standards.

    Transform pharmacovigilance by leveraging data and advanced analytics


    To ensure patient safety and mitigate the risks associated with adverse events (AEs), life sciences companies are proactively monitoring and assessing the benefit-risk profile of a medicinal product early in the product’s life cycle. Modern advanced analytics techniques are raising the bar even further. By examining large and varied data sets containing safety information, companies can uncover hidden patterns, trends, and patient preferences and gain insights to comply with AEs reporting requirements and also predict and prevent them. Through AI-enabled analytics, companies are transitioning from mere reporting and monitoring (what happened and what is happening now) to evaluation, prediction, and prescription (why did it happen, what will happen next, what to do to prevent it).

    Leverage our expertise in the regulatory submission process, AE reconciliation, and enhanced safety monitoring and corrective actions to increase the success rate of your clinical trials!


    Read Blog / The innovative path forward in clinical trials

    Events monitoring

    Service offering

    Key results

    Business outcomes

    • Process excellence for data capture and transmission
    • Signal detection with advanced analytics
    • Data harmonization using standards

    Signal detection proof of concept


    Roadmap to apply automation


    Steps to adopt data standards

    Clinical program access

    • Design clinical trials with an emphasis on patients with critical diagnosis even before early access programs (EAPs) and in line with managed access programs.

    Agile clinical development

    • Enroll faster, retain patients longer, and reach a more representative patient population.

    Axtria clinical research hub


    2023-2024 Challenges and Opportunities for Orthopedic Device Companies


    Laboratory Information Systems: Transforming The Way Medical Device Companies Do Business


    COVID-19: AI and Big Data for Treatment, Containment, and Flattening the Curve